Anna Malykhina
Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder | 30 | 2023 | 180 | 7.730 |
Why?
| Lower Urinary Tract Symptoms | 10 | 2022 | 47 | 3.910 |
Why?
| Urinary Bladder, Overactive | 10 | 2021 | 20 | 2.920 |
Why?
| Urination | 10 | 2022 | 40 | 2.870 |
Why?
| Potassium Channels, Tandem Pore Domain | 4 | 2019 | 11 | 2.490 |
Why?
| Muscle Contraction | 13 | 2019 | 415 | 2.270 |
Why?
| Muscle, Smooth | 9 | 2017 | 159 | 2.160 |
Why?
| Urinary Bladder, Neurogenic | 4 | 2022 | 32 | 2.030 |
Why?
| Multiple Sclerosis | 6 | 2022 | 395 | 1.760 |
Why?
| Pelvic Pain | 3 | 2022 | 38 | 1.690 |
Why?
| Colon | 7 | 2014 | 241 | 1.630 |
Why?
| TRPV Cation Channels | 6 | 2021 | 35 | 1.600 |
Why?
| Coronavirus Infections | 3 | 2022 | 349 | 1.410 |
Why?
| Sensory Receptor Cells | 3 | 2022 | 85 | 1.300 |
Why?
| Urinary Bladder Diseases | 5 | 2019 | 20 | 1.270 |
Why?
| Cystitis, Interstitial | 4 | 2014 | 16 | 1.090 |
Why?
| Murine hepatitis virus | 3 | 2022 | 16 | 1.060 |
Why?
| Protein Kinase C | 3 | 2015 | 314 | 1.030 |
Why?
| Urinary Bladder Neck Obstruction | 4 | 2023 | 21 | 0.960 |
Why?
| Colitis | 7 | 2014 | 227 | 0.920 |
Why?
| Lumbosacral Region | 1 | 2022 | 52 | 0.830 |
Why?
| Mice, Inbred C57BL | 13 | 2022 | 5020 | 0.820 |
Why?
| Pain Perception | 1 | 2022 | 36 | 0.810 |
Why?
| Urinary Tract Infections | 2 | 2014 | 143 | 0.800 |
Why?
| Administration, Intravesical | 3 | 2017 | 23 | 0.790 |
Why?
| Neuronal Plasticity | 2 | 2013 | 224 | 0.780 |
Why?
| Receptor, Muscarinic M3 | 1 | 2020 | 3 | 0.770 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 14 | 0.770 |
Why?
| Receptor, Adenosine A1 | 1 | 2020 | 11 | 0.770 |
Why?
| Nociception | 1 | 2020 | 17 | 0.760 |
Why?
| Calcitonin Gene-Related Peptide | 4 | 2016 | 32 | 0.760 |
Why?
| Analgesics | 1 | 2022 | 163 | 0.750 |
Why?
| Substance P | 4 | 2016 | 44 | 0.750 |
Why?
| Coronavirus | 3 | 2022 | 42 | 0.720 |
Why?
| Hyperalgesia | 1 | 2020 | 108 | 0.710 |
Why?
| Neuroglia | 1 | 2020 | 153 | 0.710 |
Why?
| Animals | 35 | 2023 | 34133 | 0.690 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 49 | 0.690 |
Why?
| Chronic Pain | 1 | 2022 | 214 | 0.640 |
Why?
| Inflammation | 5 | 2020 | 2598 | 0.620 |
Why?
| Urodynamics | 5 | 2019 | 31 | 0.610 |
Why?
| Urethra | 1 | 2017 | 57 | 0.610 |
Why?
| Mice | 18 | 2023 | 15888 | 0.570 |
Why?
| Urogenital System | 1 | 2016 | 17 | 0.570 |
Why?
| Urinary Tract | 1 | 2016 | 40 | 0.560 |
Why?
| Diterpenes | 2 | 2012 | 33 | 0.540 |
Why?
| Cannabinoids | 1 | 2017 | 120 | 0.540 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2022 | 537 | 0.530 |
Why?
| Phenotype | 3 | 2019 | 3070 | 0.530 |
Why?
| Encephalomyelitis | 1 | 2014 | 9 | 0.500 |
Why?
| Marijuana Use | 1 | 2017 | 158 | 0.500 |
Why?
| Estrous Cycle | 1 | 2014 | 17 | 0.500 |
Why?
| Cystitis | 1 | 2014 | 22 | 0.490 |
Why?
| Ganglia, Spinal | 5 | 2014 | 45 | 0.490 |
Why?
| Gastrointestinal Diseases | 1 | 2016 | 195 | 0.490 |
Why?
| Neuropeptides | 1 | 2014 | 70 | 0.480 |
Why?
| Male | 32 | 2023 | 59639 | 0.480 |
Why?
| Demyelinating Diseases | 1 | 2014 | 79 | 0.470 |
Why?
| Disease Models, Animal | 12 | 2022 | 3799 | 0.460 |
Why?
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2010 | 21 | 0.460 |
Why?
| Erectile Dysfunction | 1 | 2013 | 37 | 0.450 |
Why?
| Penis | 1 | 2013 | 38 | 0.450 |
Why?
| Viscera | 1 | 2012 | 16 | 0.450 |
Why?
| Rats, Sprague-Dawley | 8 | 2015 | 2501 | 0.440 |
Why?
| Peripheral Nerves | 1 | 2012 | 65 | 0.440 |
Why?
| Neural Pathways | 1 | 2014 | 289 | 0.430 |
Why?
| Colonic Diseases | 1 | 2012 | 27 | 0.420 |
Why?
| Trinitrobenzenesulfonic Acid | 5 | 2012 | 9 | 0.400 |
Why?
| Motor Neurons | 1 | 2012 | 220 | 0.380 |
Why?
| Color Vision Defects | 1 | 2010 | 6 | 0.370 |
Why?
| Retinal Cone Photoreceptor Cells | 1 | 2010 | 18 | 0.360 |
Why?
| Neurons | 3 | 2013 | 1345 | 0.350 |
Why?
| Rats | 8 | 2014 | 5426 | 0.350 |
Why?
| Doxorubicin | 2 | 2021 | 304 | 0.340 |
Why?
| Protein Subunits | 1 | 2010 | 215 | 0.340 |
Why?
| Biomarkers | 3 | 2017 | 3662 | 0.330 |
Why?
| Calcium Channels | 3 | 2021 | 154 | 0.310 |
Why?
| Central Nervous System | 2 | 2022 | 244 | 0.300 |
Why?
| Pons | 2 | 2017 | 31 | 0.290 |
Why?
| Lactams, Macrocyclic | 2 | 2017 | 48 | 0.290 |
Why?
| Benzoquinones | 2 | 2017 | 45 | 0.290 |
Why?
| Mice, Transgenic | 3 | 2022 | 2079 | 0.280 |
Why?
| Female | 20 | 2022 | 63629 | 0.260 |
Why?
| Vincristine | 2 | 2022 | 99 | 0.250 |
Why?
| Mutation | 3 | 2010 | 3493 | 0.250 |
Why?
| Brain-Derived Neurotrophic Factor | 2 | 2016 | 115 | 0.250 |
Why?
| Channelopathies | 1 | 2004 | 5 | 0.240 |
Why?
| Physical Stimulation | 2 | 2014 | 80 | 0.230 |
Why?
| Humans | 26 | 2022 | 122796 | 0.230 |
Why?
| Tocotrienols | 1 | 2023 | 5 | 0.230 |
Why?
| Receptors, Muscarinic | 2 | 2018 | 18 | 0.230 |
Why?
| Muscarinic Agonists | 2 | 2020 | 10 | 0.230 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 839 | 0.230 |
Why?
| Fluorescent Antibody Technique | 2 | 2022 | 420 | 0.220 |
Why?
| Gastrointestinal Tract | 1 | 2004 | 176 | 0.200 |
Why?
| Signal Transduction | 6 | 2021 | 4902 | 0.200 |
Why?
| Peripheral Nervous System Diseases | 1 | 2022 | 126 | 0.200 |
Why?
| Receptor, Serotonin, 5-HT2A | 1 | 2021 | 19 | 0.200 |
Why?
| Benzilates | 1 | 2020 | 1 | 0.190 |
Why?
| Nortropanes | 1 | 2020 | 1 | 0.190 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 2020 | 7 | 0.190 |
Why?
| Purinergic P1 Receptor Agonists | 1 | 2020 | 8 | 0.190 |
Why?
| Genes, Synthetic | 1 | 2020 | 14 | 0.190 |
Why?
| Xanthines | 1 | 2020 | 15 | 0.190 |
Why?
| Freund's Adjuvant | 1 | 2020 | 18 | 0.190 |
Why?
| Clozapine | 1 | 2020 | 21 | 0.190 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2022 | 346 | 0.190 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 2359 | 0.190 |
Why?
| Touch | 1 | 2020 | 33 | 0.190 |
Why?
| Theophylline | 1 | 2020 | 64 | 0.190 |
Why?
| Constipation | 1 | 2021 | 75 | 0.180 |
Why?
| Mice, Knockout | 2 | 2019 | 2737 | 0.180 |
Why?
| Smooth Muscle Myosins | 1 | 2019 | 9 | 0.180 |
Why?
| RNA-Binding Proteins | 1 | 2022 | 392 | 0.170 |
Why?
| Muscle Relaxation | 1 | 2019 | 32 | 0.170 |
Why?
| Myosin Light Chains | 1 | 2019 | 35 | 0.170 |
Why?
| Neurons, Afferent | 2 | 2012 | 92 | 0.170 |
Why?
| Comorbidity | 2 | 2016 | 1600 | 0.170 |
Why?
| Gene Expression Profiling | 2 | 2023 | 1625 | 0.170 |
Why?
| Receptors, Purinergic P2X1 | 1 | 2018 | 4 | 0.170 |
Why?
| Cholinergic Fibers | 1 | 2018 | 19 | 0.170 |
Why?
| Gene Frequency | 2 | 2018 | 522 | 0.170 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 115 | 0.170 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2020 | 207 | 0.170 |
Why?
| Hot Temperature | 1 | 2020 | 345 | 0.160 |
Why?
| Spinal Cord | 2 | 2014 | 364 | 0.160 |
Why?
| White Matter | 1 | 2019 | 119 | 0.160 |
Why?
| Caveolins | 1 | 2017 | 6 | 0.160 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 373 | 0.150 |
Why?
| Recombinant Fusion Proteins | 1 | 2020 | 661 | 0.150 |
Why?
| Urinary Incontinence, Urge | 1 | 2017 | 2 | 0.150 |
Why?
| Lumbosacral Plexus | 2 | 2017 | 7 | 0.150 |
Why?
| Postmenopause | 2 | 2016 | 307 | 0.150 |
Why?
| Brain Stem | 1 | 2017 | 104 | 0.150 |
Why?
| Cancer Survivors | 1 | 2021 | 225 | 0.150 |
Why?
| Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 19 | 0.150 |
Why?
| Reflex | 2 | 2018 | 64 | 0.140 |
Why?
| Age Factors | 4 | 2019 | 3114 | 0.140 |
Why?
| Botulinum Toxins, Type A | 1 | 2017 | 43 | 0.140 |
Why?
| Nerve Growth Factor | 1 | 2016 | 28 | 0.140 |
Why?
| Pilot Projects | 2 | 2019 | 1477 | 0.140 |
Why?
| Cytoskeleton | 1 | 2017 | 183 | 0.140 |
Why?
| Electric Stimulation | 3 | 2012 | 273 | 0.140 |
Why?
| Promoter Regions, Genetic | 1 | 2020 | 1188 | 0.140 |
Why?
| Chromatography, Liquid | 1 | 2017 | 356 | 0.140 |
Why?
| Phorbol 12,13-Dibutyrate | 1 | 2015 | 11 | 0.130 |
Why?
| Phorbol Esters | 1 | 2015 | 18 | 0.130 |
Why?
| Myocytes, Smooth Muscle | 1 | 2017 | 244 | 0.130 |
Why?
| Polymorphism, Genetic | 1 | 2018 | 666 | 0.130 |
Why?
| RNA, Small Interfering | 1 | 2017 | 581 | 0.130 |
Why?
| Pyuria | 1 | 2014 | 3 | 0.130 |
Why?
| Bacteriuria | 1 | 2014 | 8 | 0.130 |
Why?
| Down-Regulation | 1 | 2017 | 654 | 0.120 |
Why?
| Severity of Illness Index | 3 | 2019 | 2784 | 0.120 |
Why?
| Pituitary-Adrenal System | 1 | 2016 | 179 | 0.120 |
Why?
| Brain Diseases | 1 | 2016 | 141 | 0.120 |
Why?
| Urologic Diseases | 1 | 2014 | 38 | 0.120 |
Why?
| Carbachol | 2 | 2011 | 21 | 0.120 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2016 | 215 | 0.120 |
Why?
| Nerve Growth Factors | 1 | 2014 | 71 | 0.120 |
Why?
| Immunohistochemistry | 2 | 2010 | 1727 | 0.120 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 240 | 0.120 |
Why?
| Peroxidase | 1 | 2014 | 182 | 0.120 |
Why?
| Potassium Channels | 1 | 2014 | 137 | 0.120 |
Why?
| Voltage-Gated Sodium Channels | 1 | 2012 | 3 | 0.110 |
Why?
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2012 | 10 | 0.110 |
Why?
| Adult | 7 | 2019 | 32385 | 0.110 |
Why?
| Afferent Pathways | 1 | 2013 | 44 | 0.110 |
Why?
| Genotype | 1 | 2018 | 1943 | 0.110 |
Why?
| Cholinergic Neurons | 1 | 2012 | 17 | 0.110 |
Why?
| Gonadal Steroid Hormones | 1 | 2014 | 123 | 0.110 |
Why?
| Organ Culture Techniques | 1 | 2013 | 152 | 0.110 |
Why?
| Blotting, Western | 2 | 2012 | 1225 | 0.110 |
Why?
| Case-Control Studies | 3 | 2019 | 3296 | 0.110 |
Why?
| In Vitro Techniques | 1 | 2014 | 1130 | 0.100 |
Why?
| Proteomics | 1 | 2017 | 890 | 0.100 |
Why?
| Premenopause | 1 | 2011 | 109 | 0.100 |
Why?
| Cholinergic Agents | 1 | 2011 | 18 | 0.100 |
Why?
| Cytokines | 1 | 2019 | 1928 | 0.100 |
Why?
| Data Interpretation, Statistical | 1 | 2012 | 345 | 0.100 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2018 | 2127 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 1981 | 0.090 |
Why?
| Sex Factors | 1 | 2016 | 1860 | 0.090 |
Why?
| Neuralgia | 1 | 2011 | 115 | 0.090 |
Why?
| Follow-Up Studies | 1 | 2019 | 4768 | 0.090 |
Why?
| Mutant Proteins | 1 | 2010 | 101 | 0.090 |
Why?
| Ion Channel Gating | 1 | 2010 | 90 | 0.090 |
Why?
| Incidence | 1 | 2016 | 2527 | 0.090 |
Why?
| Models, Animal | 1 | 2011 | 373 | 0.090 |
Why?
| Amino Acid Substitution | 1 | 2010 | 278 | 0.080 |
Why?
| Prospective Studies | 5 | 2021 | 6704 | 0.080 |
Why?
| Recurrence | 1 | 2011 | 998 | 0.080 |
Why?
| Protein Transport | 1 | 2010 | 418 | 0.080 |
Why?
| Acute Disease | 1 | 2011 | 984 | 0.080 |
Why?
| Prognosis | 1 | 2016 | 3563 | 0.080 |
Why?
| Middle Aged | 7 | 2019 | 28563 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1003 | 0.080 |
Why?
| Hypertrophy | 2 | 2019 | 125 | 0.080 |
Why?
| Stress, Psychological | 1 | 2016 | 1021 | 0.080 |
Why?
| Brain | 1 | 2019 | 2540 | 0.080 |
Why?
| Evidence-Based Medicine | 1 | 2012 | 731 | 0.080 |
Why?
| HEK293 Cells | 1 | 2010 | 651 | 0.080 |
Why?
| src-Family Kinases | 2 | 2007 | 109 | 0.070 |
Why?
| Neoplasms | 1 | 2021 | 2235 | 0.070 |
Why?
| Trinucleotide Repeat Expansion | 1 | 2006 | 26 | 0.070 |
Why?
| Trinucleotide Repeats | 1 | 2006 | 24 | 0.070 |
Why?
| Iron-Binding Proteins | 1 | 2006 | 37 | 0.070 |
Why?
| Risk Assessment | 1 | 2016 | 3213 | 0.070 |
Why?
| Irritable Bowel Syndrome | 1 | 2006 | 30 | 0.070 |
Why?
| Tyrosine | 1 | 2007 | 267 | 0.070 |
Why?
| Sacrum | 1 | 2005 | 63 | 0.070 |
Why?
| Cerebellum | 1 | 2006 | 205 | 0.060 |
Why?
| Aged | 4 | 2017 | 20495 | 0.060 |
Why?
| Quality of Life | 2 | 2011 | 2457 | 0.060 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 217 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 1 | 2007 | 442 | 0.060 |
Why?
| Action Potentials | 1 | 2006 | 433 | 0.060 |
Why?
| Ion Channels | 1 | 2004 | 130 | 0.060 |
Why?
| Electrophysiology | 3 | 2010 | 205 | 0.060 |
Why?
| RNA, Messenger | 1 | 2010 | 2720 | 0.050 |
Why?
| Child, Preschool | 1 | 2016 | 9755 | 0.050 |
Why?
| Mice, Inbred BALB C | 2 | 2019 | 1245 | 0.050 |
Why?
| Child | 2 | 2021 | 19561 | 0.050 |
Why?
| Models, Biological | 2 | 2010 | 1756 | 0.050 |
Why?
| Interleukin-2 | 1 | 2022 | 420 | 0.050 |
Why?
| Administration, Oral | 1 | 2023 | 786 | 0.050 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 10 | 0.040 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2019 | 26 | 0.040 |
Why?
| Anxiety, Separation | 1 | 2018 | 16 | 0.040 |
Why?
| Maternal Deprivation | 1 | 2018 | 14 | 0.040 |
Why?
| Risk Factors | 1 | 2011 | 9381 | 0.040 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3264 | 0.040 |
Why?
| Animals, Newborn | 1 | 2018 | 825 | 0.030 |
Why?
| Young Adult | 1 | 2011 | 11094 | 0.030 |
Why?
| Bethanechol | 1 | 2014 | 3 | 0.030 |
Why?
| Atropine | 1 | 2014 | 37 | 0.030 |
Why?
| Muscarinic Antagonists | 1 | 2014 | 29 | 0.030 |
Why?
| Retrospective Studies | 1 | 2011 | 13433 | 0.030 |
Why?
| Phosphorylation | 1 | 2019 | 1733 | 0.030 |
Why?
| Health Surveys | 1 | 2016 | 468 | 0.030 |
Why?
| Surveys and Questionnaires | 2 | 2016 | 4882 | 0.030 |
Why?
| Hydrocortisone | 1 | 2016 | 315 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6682 | 0.030 |
Why?
| Cross-Sectional Studies | 2 | 2016 | 4734 | 0.030 |
Why?
| Phenanthrenes | 1 | 2012 | 11 | 0.030 |
Why?
| Adolescent | 1 | 2011 | 18948 | 0.030 |
Why?
| Carboxylic Acids | 1 | 2012 | 30 | 0.030 |
Why?
| Calcium | 2 | 2010 | 1244 | 0.030 |
Why?
| Adenosine Triphosphate | 1 | 2014 | 456 | 0.030 |
Why?
| Catastrophization | 1 | 2011 | 10 | 0.030 |
Why?
| Heart Rate | 1 | 2016 | 756 | 0.030 |
Why?
| Intestinal Diseases | 1 | 2011 | 31 | 0.030 |
Why?
| Benzimidazoles | 1 | 2012 | 142 | 0.030 |
Why?
| Rabbits | 1 | 2012 | 808 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 2016 | 569 | 0.030 |
Why?
| Circular Dichroism | 1 | 2010 | 138 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 336 | 0.020 |
Why?
| Protein Stability | 1 | 2010 | 162 | 0.020 |
Why?
| Anxiety | 1 | 2016 | 888 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2010 | 341 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2012 | 836 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2010 | 319 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 2010 | 536 | 0.020 |
Why?
| Cholinergic Agonists | 1 | 2007 | 7 | 0.020 |
Why?
| Potassium Chloride | 1 | 2007 | 44 | 0.020 |
Why?
| Nitric Acid | 1 | 2007 | 6 | 0.020 |
Why?
| Enema | 1 | 2007 | 40 | 0.020 |
Why?
| Depression | 1 | 2016 | 1190 | 0.020 |
Why?
| Mucous Membrane | 1 | 2007 | 120 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1318 | 0.020 |
Why?
| Dextran Sulfate | 1 | 2005 | 71 | 0.020 |
Why?
| Escherichia coli | 1 | 2010 | 767 | 0.020 |
Why?
| Friedreich Ataxia | 1 | 2006 | 63 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6845 | 0.020 |
Why?
| Cell Line | 1 | 2010 | 2785 | 0.020 |
Why?
| Alleles | 1 | 2006 | 852 | 0.010 |
Why?
| Recovery of Function | 1 | 2007 | 610 | 0.010 |
Why?
|
|
Malykhina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|